Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.

Curr Med Res Opin. 2008 Mar;24(3):685-94. doi: 10.1185/030079908X273273. Epub 2008 Jan 25.

PMID:
18226326
2.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
3.

Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.

Robinson JG, Davidson MH.

Expert Rev Cardiovasc Ther. 2006 Jul;4(4):461-76. Review. Erratum in: Expert Rev Cardiovasc Ther. 2006 Sep;4(5):772.

PMID:
16918265
4.
5.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
6.

[Thoughts about the results of the "IDEAL" study].

Kalina A.

Orv Hetil. 2006 May 28;147(21):993-5. Review. Hungarian.

PMID:
16812974
7.

[Aggressive therapy and combination therapy in severe hyperlipidemia].

Kostner KM.

Wien Med Wochenschr. 1999;149(5-6):146-8. Review. German.

PMID:
10408007
8.

Ezetimibe: a novel option for lowering cholesterol.

Davidson MH.

Expert Rev Cardiovasc Ther. 2003 May;1(1):11-21. Review.

PMID:
15030293
9.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
10.

Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.

Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M.

Clin Cardiol. 2003 Nov;26(11):509-14. Review.

11.

[LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].

März W.

MMW Fortschr Med. 2003 Dec 11;145(50):46-9. Review. German.

PMID:
14963971
12.

Ezetimibe.

Darkes MJ, Poole RM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. Review.

PMID:
14727947
13.

[Ezetimibe: from pharmacology to clinical trials].

Tellier P.

Ann Endocrinol (Paris). 2003 Dec;64(6):442-7. Review. French.

PMID:
15067249
14.

Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients.

Wanner C, Krane V.

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S72-5. Review.

PMID:
12612957
15.

Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.

Kastelein JJ, Sankatsing RR.

Int J Clin Pract. 2005 Dec;59(12):1464-71. Review.

PMID:
16351680
16.

Safety of high-dose atorvastatin therapy.

Waters DD.

Am J Cardiol. 2005 Sep 5;96(5A):69F-75F. Review.

PMID:
16126026
17.

Cholesterol lowering in atherosclerosis.

Brown WV.

Am J Cardiol. 2000 Aug 24;86(4B):29H-32H. Review.

PMID:
11021253
18.

Effectiveness of statin therapy in adults with coronary heart disease.

Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, Larsen G, McCall A, Pineros S, Sales A.

Arch Intern Med. 2004 Jul 12;164(13):1427-36. Review.

PMID:
15249352
19.

A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

Tuomilehto J, Leiter LA, Kallend D.

Int J Clin Pract Suppl. 2004 Oct;(143):30-40. Review.

PMID:
16035394
20.

If LDL-C is the answer...what was the question? What do the data really show?

Katholi RE, Deitrick CL, Hardiek KJ.

Heart Dis. 2001 Jan-Feb;3(1):2-13. Review.

PMID:
11975764

Supplemental Content

Support Center